EGFR and non-small cell lung carcinoma: Although EGFR genotyping using EV-based BALF liquid biopsy was associated with a low sensitivity in stage I NSCLC, it was successful for advanced NSCLC that requires urgent and accurate EGFR mutation testing decisions.